Professor Emeritus Dr. Thomas J. Bardos Scholarship Fund

Students working in a Pharmacy Lab.

This fund provides scholarships to hardworking students who are contributing to the field as research leaders for the School of Pharmacy and Pharmaceutical Sciences.

Thomas Bardos was a generous man. He funded awards and scholarships at UB, the American Association for Cancer Research, the University of Notre Dame, the University of Illinois and in his native Hungary, and helped countless others through the years.

“Tom wanted to be a philanthropist,” says his widow Maria. To that end, Joseph Dunn, BS ’75, PhD ’81, and Maria Bardos, BA ’62, PhD ’70, helped establish the scholarship endowment in the Bardos name. The award is given annually to a deserving student in either the Doctor of Pharmacy or one of the Pharmaceutical Sciences programs.

Bardos arrived in the U.S. from Budapest, Hungary, in 1946 with nothing but a silver cigarette case in his pocket. He joined the department of medicinal chemistry in the School of Pharmacy in 1960, where he coauthored more than 200 peer-reviewed papers and chapters on cancer chemotherapy, and directed the thesis research of dozens of PhD candidates and postdoctoral associates before retiring and taking the title of emeritus professor in 1993.

Make a Difference Now

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • Meaney named ACCP Fellow
    8/14/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a Fellow of the American College of Clinical Pharmacy (ACCP).
  • UB CIGBS Announces Stop Diabetes Progression, a New Global Community Health Site Initiative
    10/18/23
    The University at Buffalo (UB) Center for Integrated Global Biomedical Sciences (CIGBS) has announced plans to launch, Stop Diabetes Progression, a new health initiative, focusing on the creation of community-based education networks in Western New York, Jamaica and Zimbabwe to engage individuals with pre-diabetes and those with an established diagnosis of diabetes mellitus. The goal of this new initiative is to stop the progression of the disease for both groups.
  • Qu receives NIH grant to develop targeted mass spectrometry assays as markers in monitoring Type 1 diabetes
    9/5/23
    Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, has been awarded a four-year $982,617 U01 grant from the National Institutes of Health (NIH). The study, called “Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications,” will develop novel, highly sensitive assays that quantify proteins or peptide hormones to effectively monitor the progression or efficacy of new clinical interventions prior to or following the onset of Type 1 diabetes.
  • Clark receives NYSCHP New Practitioner Award for 2023
    3/24/23
    Collin Clark, PharmD, clinical assistant professor, Department of Pharmacy Practice, is the recipient of the New York State Council of Health-system Pharmacists (NYSCHP) New Practitioner Award for 2023.
  • UB SPPS hosts Ann E. Weber, PhD, as 2023 David Chu lecturer
    5/9/23
    On May 8, the University of Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) welcomed Ann E. Weber, PhD, senior vice president, Research and Development, Kallyope Inc., as our 2023 David Chu Lecturer.
  • UB faculty, staff receive SUNY Chancellor’s Awards
    6/7/23

    Twenty have been recognized for consistently superior professional achievement and the ongoing pursuit of excellence.

  • UB CIGBS nominated for award honoring innovators in life sciences
    8/21/23
    UB’s Center for Integrated Global Biomedical Sciences (CIGBS) has been nominated for a 2023 Prix Galien USA award in the “Incubators, Accelerators and Equity” category.